Patent Oppositions in drug additives industry

Explore the competitive field of drug additives where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in drug additives technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the drug additives industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the drug additives industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Ophthalmic Composition Based On Hyaluronic Acid To Protect From Damages Caused By Environmental PollutionCOLOMBOMay 12, 2026MAIWALD
Cationic Lipids For Use In Lipid NanoparticlesACUITAS THERAPEUTICSMay 12, 2026GENZYME
An Improved Pharmaceutical Composition For Nasal Use, Preparation, And Use ThereofJADRAN GALENSKI LABORATORIJ DDApr 27, 2026MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
Stable Antibody FormulationREGENERON PHARMACEUTICALSApr 23, 2026STRAWMAN
Starting Dose Of Pth ConjugatesASCENDIS PHARMA BONE DISEASESApr 1, 2026TEVA PHARMACEUTICALS
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026WUESTHOFF & WUESTHOFF
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 18, 2026TEVA PHARMACEUTICALS
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026BOTTI & FERRARI
Heterotandem Bicyclic Peptide ComplexesBICYCLETXMar 9, 2026RGTH
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHFeb 27, 2026MURGITROYD

To stay ahead in the competitive drug additives industry, companies are constantly innovating. Here are the top patents facing oppositions in the drug additives industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK8
Jan 3, 2024Method For Producing Rna CompositionsCUREVAC REAL ESTATE8
Aug 2, 2023Gip/Glp1 Agonist CompositionsELI LILLY8
Sep 5, 2018Preservative Free Bimatoprost And Timolol SolutionsALLERGAN8
Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS8
Oct 25, 2023Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENT8
Jan 19, 2022Preservative Free Bimatoprost And Timolol SolutionsALLERGAN8
Jul 3, 2024Novel Pharmaceutical CompositionNOVARTIS7
Dec 30, 2020Controlled Release Pharmaceutical CompositionASTELLAS PHARMA7
Nov 22, 2017Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection DevicesNOVO NORDISK7